Background: The SynCardia total artificial heart (TAH) provides complete circulatory support by replacing both native ventricles. Accepted indications include bridge to transplantation and destination therapy. We review our experience with TAH implantation during a period when axial flow pump became available.
Methods: We retrospectively analyzed the demographics, clinical characteristics and survival of all patients receiving the TAH.
Results: From September 2004 to November 2016, 13 patients (12 men, mean age 45 ± 13 yr) received the TAH for refractory cardiogenic shock secondary to idiopathic (56%) or ischemic (17%) cardiomyopathy and to other various causes (33%). Before implantation, mean ejection fraction was 14% ± 4%, 7 (54%) patients had previous cardiac surgery, 4 (31%) were on mechanical ventilation, and 3 (23%) patients were on dialysis. The mean duration of TAH support was 46 ± 40 days. Three (23%) patients died while on support after a mean of 15 days. Actuarial survival on support was 77% ± 12% at 30 days after implantation. Complications on support included stroke ( = 1, 8%), acute respiratory distress syndrome requiring prolonged intubation ( = 5, 38%) and acute renal failure requiring temporary dialysis ( = 5, 38%). Ten (77%) patients survived to be transplanted after a mean of 52 ± 42 days of support. Actuarial survival rates after transplant were 67% ± 16% at 1 month and 56% ± 17% at 1 year after transplantation.
Conclusion: The TAH provides an alternative with low incidence of neurologic events in extremely fragile and complex patients waiting for heart transplantation. Complex and unusual anatomic conditions explained the current use of TAH.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726965 | PMC |
| http://dx.doi.org/10.1503/cjs.003617 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Total Artificial Heart Implantation as a Bridge to Transplantation in Slovakia.
Thorac Cardiovasc Surg
September 2024
Department of Cardiac Surgery, Faculty of Medicine of the Comenius University, National Institute for Cardiovascular diseases, Bratislava, Slovakia.
Although left ventricular assist device implantation represents the majority of durable mechanical circulatory support implants for patients with advanced heart failure, as many as 20 to 30% will subsequently have right heart failure requiring extended inotropic support or short-term mechanical circulatory support, and the total artificial heart is an established tool in the bridge to transplant armamentarium. The aim of this short report is to present our center's experience with the use of SynCardia total artificial heart. Between November 2017 and April 2021, 10 SynCardia total artificial heart devices were implanted.
View Article and Find Full Text PDFOutcomes after SynCardia® temporary total artificial heart implantation: A 20-year single-center experience in 196 patients.
Artif Organs
September 2024
Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany.
Background: The SynCardia® temporary total artificial heart (TAH) serves as a mechanical circulatory support device for patients suffering from irreversible biventricular failure.
Methods: This retrospective study analyzed 196 consecutive patients who underwent TAH implantation at our center from 2001 to 2021. We assessed survival rates and all-cause mortality during TAH support, including survival post-heart transplantation.
Birth in the Operating Room for Immediate Cardiac Surgery: A Rare but Effective Strategy.
World J Pediatr Congenit Heart Surg
November 2024
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Article Synopsis
- Significant advancements in fetal cardiac imaging have allowed for earlier diagnosis of complex congenital heart disease (CHD) in infants at high risk for postnatal issues, prompting a new strategy for immediate surgical intervention.
- Between 2012 and 2023, eight prenatally diagnosed CHD infants were delivered in an operating room next to a cardiac OR, with six undergoing surgery on their birth day for conditions like obstructed total anomalous pulmonary venous return (TAPVR).
- The overall five-year postoperative survival rate for these infants was 88%, indicating that this interdisciplinary approach to birth and immediate care may lead to better outcomes compared to historical data.
Ex Vivo Lung Perfusion and Primary Graft Dysfunction Following Lung Transplantation: A Contemporary United Network for Organ Sharing Database Analysis.
J Clin Med
July 2024
Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Primary graft dysfunction (PGD) has detrimental effects on recipients following lung transplantation. Here, we determined the contemporary trends of PGD in a national database, factors associated with the development of PGD grade 3 (PGD3) and ex vivo lung perfusion's (EVLP) effect on this harmful postoperative complication. The United Network for Organ Sharing database was queried from 2015 to 2023, and recipients were stratified into No-PGD, PGD1/2, or PGD3.
View Article and Find Full Text PDFComparing Outcomes of Post-Cardiotomy Cardiogenic Shock Patients: On-Site Cannulation vs. Retrieval for V-A ECMO Support.
J Clin Med
May 2024
Specialty Critical Care, Advanced Cardiac Care and Acute Circulatory Support, Nazih Zuhdi Transplant Institute, Integris Baptist Medical Center, Oklahoma City, OK 73112, USA.
Post-cardiotomy cardiogenic shock (PCCS) remains a life-threatening complication after cardiac surgery. Extracorporeal membrane oxygenation (ECMO) represents the mainstay of mechanical circulatory support for PCCS; however, its availability is limited to larger experienced centers, leading to a mismatch between centers performing cardiac surgery and hospitals offering ECMO management beyond cannulation. We sought to evaluate the outcomes and complications of PCCS patients requiring veno-arterial (V-A) ECMO cannulated at our hospital compared to those cannulated at referral hospitals.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!